An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis (DEFINE): A Phase Ib/IIa Randomised Controlled Trial.

Erin E GaughanTom M QuinnAndrew MillsAnnya M BruceJean AntonelliAlison MacKinnonVassilios AslanisFeng LiRichard O'ConnorCecilia BozRoss MillsPhilip EmanuelMatthew BurgessGiulia RinaldiAsta ValanciuteBethany MillsEmma ScholefieldGareth HardistyEmily Gwyer FindlayRichard A ParkerJohn NorrieJames W DearAhsan R AkramOliver KochKate TempletonDavid H DockrellTimothy S WalshStephen PartridgeDuncan HumphriesJie Wang-JairajRobert J SlackHans SchambyeDe PhungLise GravelleBertil LindmarkManu Shankar-HariNikhil HiraniTariq SethiKevin Dhaliwal

Published in: American journal of respiratory and critical care medicine (2022)

gov, ID: NCT04473053. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Keyphrases

coronavirus disease
sars cov
study protocol
minimally invasive
cystic fibrosis
interstitial lung disease
randomized controlled trial
respiratory syndrome coronavirus
neural network
clinical trial